Moreover, many studies revealed a correlation between increased MMP-2/9 expression and worst outcome of CRC suggesting that the control of the expression and/or the activity of these proteolytic enzymes may offer a new therapeutic opportunity for treating this highly invasive cancer [66]. Here, MMP2 is linked to colorectal carcinoma.